Filtros de búsqueda

Lista de obras de Xavier Pivot

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.

artículo científico publicado en 2013

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

artículo científico publicado en 2019

A Randomized Phase I Pharmacokinetic Study Comparing Biosimilar Candidate SB3 and Trastuzumab in Healthy Male Subjects.

artículo científico publicado en 2016

A Randomized Phase I Study Comparing the Pharmacokinetics of HD201, a Trastuzumab Biosimilar, With European Union-sourced Herceptin.

artículo científico publicado en 2018

A limited sampling strategy for determining carboplatin AUC and monitoring drug dosage.

artículo científico publicado en 2000

A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II study

artículo científico publicado en 2011

A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil

artículo científico publicado en 1999

A multivariate analysis for predicting cisplatin-induced delayed emesis

artículo científico publicado en 2000

A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study.

artículo científico publicado en 2017

A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results.

artículo científico publicado en 2018

A phenotypic and mechanistic perspective on heterogeneity of HER2-positive breast cancers

artículo científico publicado en 2016

A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trial.

artículo científico publicado en 2014

A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer.

artículo científico publicado en 2013

A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies.

artículo científico publicado en 2008

A retrospective study of first indicators of breast cancer recurrence

scientific article published on 01 April 2000

A time and motion study of subcutaneous versus intravenous trastuzumab in patients with HER2-positive early breast cancer

artículo científico publicado en 2016

A unified definition of clinical anthracycline resistance breast cancer.

artículo científico publicado en 2000

A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers

artículo científico publicado en 2016

Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer.

scientific article published on 13 August 2009

Adjuvant Trastuzumab Is Required in Human Epidermal Growth Factor Receptor 2-Positive Node-Negative Breast Cancer Patients Regardless of Tumour Size

artículo científico publicado en 2020

Adjuvant chemotherapy for local relapse breast cancer

scientific article published on 16 January 2014

Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience

artículo científico publicado en 1998

Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy

artículo científico publicado en 2014

Age, Neurological Status MRC Scale, and Postoperative Morbidity are Prognostic Factors in Patients with Glioblastoma Treated by Chemoradiotherapy.

scientific article published on 17 August 2016

An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemia

scientific article published on 01 May 2000

Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response.

artículo científico publicado en 2012

Anthracycline-Resistant Breast Cancer

scientific article published on 01 December 1997

Anticancer therapy in patients with porphyrias: evidence today

scientific article published on 01 March 2008

Arthralgia and aromatase inhibitors

artículo científico publicado en 2013

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences

artículo científico publicado en 2019

Awareness and Misconceptions of Breast Cancer Risk Factors Among Laypersons and Physicians

artículo científico publicado en 2018

Beliefs and behavior regarding e-cigarettes in a large cross-sectional survey.

artículo científico publicado en 2018

Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer.

artículo científico publicado en 2010

Bevacizumab in first-line treatment of metastatic breast cancer: a viewpoint by Xavier Pivot

artículo científico publicado en 2007

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer.

artículo científico publicado en 2013

Breast cancer screening controversy: too much or not enough?

artículo científico publicado en 2015

Cancer screening in France: 10 years of analysis of behaviours by the EDIFICE surveys

artículo científico publicado en 2017

Cancer screening in France: subjects' and physicians' attitudes

artículo científico publicado en 2007

Cancer screening in France: third edition of the EDIFICE survey

artículo científico publicado en 2015

Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?

artículo científico publicado en 2008

Cardiac toxicity events in the PHARE trial, an adjuvant trastuzumab randomised phase III study.

artículo científico publicado en 2015

Challenges in the implementation of trastuzumab biosimilars: an expert panel's recommendations.

artículo científico

Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study--trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01).

artículo científico publicado en 2003

Cisplatin nephrotoxicity: a multivariate analysis of potential predisposing factors.

artículo científico publicado en 1997

Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review.

artículo científico publicado en 2014

Classic cytotoxic drugs: a narrow path for regulatory approval.

artículo científico publicado en 2017

Clinical and economic impact of epoetin in adjuvant-chemotherapy for breast cancer

artículo científico publicado en 2006

Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma.

artículo científico publicado en 2014

Clinical prognostic factors for patients with recurrent head and neck cancer: implications for randomized trials.

artículo científico publicado en 2001

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.

artículo científico publicado en 2010

Co-variables influencing 5-fluorouracil clearance during continuous venous infusion. A NONMEM analysis.

artículo científico publicado en 1998

Combination of mitoxantrone-vinorelbine as first-line chemotherapy for metastatic breast carcinoma

artículo científico publicado en 1995

Complete histologic response induced by sorafenib in advanced hepatocellular carcinoma: a case report.

artículo científico publicado en 2011

Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study.

artículo científico publicado en 1998

Concomitant bifractionated radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in locally progressive, non-resectable epidermoid carcinomas of the pharynx: ten years experience at the Antoine Lacassagne center

artículo científico publicado en 2001

Cost-utility analyses of drug therapies in breast cancer: a systematic review.

artículo científico publicado en 2016

Critical appraisal of health-state utility values used in breast cancer-related cost-utility analyses

artículo científico publicado en 2017

Discordances in estrogen receptor status, progesterone receptor status, and HER2 status between primary breast cancer and metastasis.

artículo científico publicado en 2013

Docetaxel chemotherapy induces transverse superficial loss of the nail plate

scientific article published on 01 November 1997

Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumors.

artículo científico publicado en 2010

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of squamous cell carcinoma of the head and neck

scientific article published on 01 July 2003

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of squamous cell carcinoma of the head and neck (SCCHN)

artículo científico publicado en 2005

Economic impact of prescribing error prevention with computerized physician order entry of injectable antineoplastic drugs.

artículo científico publicado en 2012

Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: results from AVADO

artículo científico publicado en 2011

Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine

artículo científico publicado en 2007

Efficacy and safety of ixabepilone (BMS-247550), a novel epothilone B analogue

artículo científico publicado en 2008

Efficacy and safety of ixabepilone, a novel epothilone analogue.

artículo científico publicado en 2007

Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study

artículo científico publicado en 2017

Efficacy of trabectedin in metastatic solitary fibrous tumor.

artículo científico publicado en 2011

Efficacy, safety and cost of eribulin in patients with metastatic breast cancer

artículo científico publicado en 2015

Emilia: use cunning to survive cancer.

artículo científico publicado en 2018

Endpoints in cancer clinical trials

artículo científico

Enterocolitis in Patients with Cancer Treated with Docetaxel.

artículo científico publicado en 2018

Epidermal growth factor receptors (EGFR): a new target for anticancer therapy

artículo científico publicado en 2003

Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injury.

artículo científico publicado en 2012

Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer.

artículo científico publicado en 2016

First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report.

artículo científico publicado en 2017

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients.

artículo científico publicado en 2010

First-line bevacizumab plus taxane-based chemotherapy for metastatic breast cancer: cost-minimisation analysis.

artículo científico publicado en 2012

First-line trastuzumab plus taxane-based chemotherapy for metastatic breast cancer: cost-minimization analysis.

artículo científico publicado en 2013

First-line vinorelbine-mitoxantrone combination in metastatic breast cancer patients relapsing after an adjuvant anthracycline regimen: results of a phase II study

scientific article published on 01 September 1998

Fluctuating Behavior of the French Population in Cancer Screening: 5th Edition of the EDIFICE Survey.

artículo científico publicado en 2018

Follow-up of patients with localized breast cancer and first indicators of advanced breast cancer recurrence: A retrospective study.

artículo científico publicado en 2017

HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant-adjuvant trastuzumab after 2 years of treatment-free follow-up.

artículo científico publicado en 2016

Hemodialysis does not affect everolimus pharmacokinetics: two cases of patients with metastatic renal cell cancer

scientific article published on 15 October 2012

Immunomodulatory effects of everolimus in a long responsive patient with metastatic renal cell carcinoma

artículo científico publicado en 2014

Impact of Chemotherapy Beyond the Third Line in Patients With Recurrent Epithelial Ovarian Cancer

artículo científico publicado en 2016

Impact of chemotherapy beyond the first line in patients with metastatic breast cancer

artículo científico publicado en 2007

Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinoma

artículo científico publicado en 2014

Impact of general practitioners' sex and age on systematic recommendation for cancer screening.

artículo científico publicado en 2011

Impact of glycosylation on the effect of cytokines. A special focus on oncology.

artículo científico publicado en 2002

Impact of organised programs on colorectal cancer screening.

artículo científico publicado en 2008

Impact of platinum complexes on dihydropyrimidine dehydrogenase activity in 5-fluorouracil-treated patients.

artículo científico publicado en 2003

Impact of sunitinib pharmacokinetic monitoring in a patient with metastatic renal cell carcinoma undergoing hemodialysis

artículo científico publicado en 2011

Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer

scientific article published on 15 May 2007

In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial

scientific article published on 19 March 2018

In the era of genomics, should tumor size be reconsidered as a criterion for neoadjuvant chemotherapy?

artículo científico publicado en 2015

Incidence and risk factors of anemia in patients with early breast cancer treated by adjuvant chemotherapy.

artículo científico publicado en 2011

International network of cancer genome projects

artículo científico publicado en 2010

Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study ⬇️

artículo científico publicado el 15 de diciembre de 2011

Is extracapsular tumour spread a prognostic factor in patients with early breast cancer?

artículo científico publicado en 2012

Ixabepilone, a novel epothilone analog in the treatment of breast cancer

scientific article published on 01 April 2008

Ixabepilone: a new active chemotherapy in the treatment of breast cancer.

artículo científico publicado en 2009

Lack of adaptation to severe malnutrition in elderly patients.

artículo científico publicado en 2002

Landscape of somatic mutations in 560 breast cancer whole-genome sequences

artículo científico publicado en 2016

Liver metastases from head and neck squamous cell carcinomas: radiological and biological features

artículo científico publicado en 2004

Long-term follow-up of patients with metastatic breast cancer treated by trastuzumab: impact of institutions.

artículo científico publicado en 2013

Lung cancer risks, beliefs and healthcare access among the underprivileged.

artículo científico publicado en 2015

MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy.

artículo científico

Maintenance hormonal treatment improves progression free survival after a first line chemotherapy in patients with metastatic breast cancer

artículo científico publicado en 2008

Mammography utilization in women aged 40–49 years

artículo científico publicado en 2011

Melanoma risk-takers: fathers and sons

artículo científico publicado en 2015

Metronomic cyclophosphamide therapy in hormone-naive patients with non-metastatic biochemical recurrent prostate cancer: a phase II trial

artículo científico publicado en 2016

Molecularly targeted agents: their promise as cancer chemopreventive interventions.

artículo científico publicado en 2005

Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines

artículo científico publicado en 2011

Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes

scientific article published on 01 March 2007

New advances in DPYD genotype and risk of severe toxicity under capecitabine.

artículo científico publicado en 2017

Organized colorectal cancer screening programmes

artículo científico publicado en 2011

Organized colorectal cancer screening programmes: how to optimize efficiency among general practitioners.

artículo científico publicado en 2011

Organizing medical oncology care at a regional level and its subsequent impact on the quality of early breast cancer management: a before-after study

artículo científico publicado en 2014

Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project

artículo científico publicado en 2018

Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study

artículo científico publicado en 2017

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study.

artículo científico publicado en 2014

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck

artículo científico publicado en 2001

Pertuzumab monotherapy after trastuzumab-based treatment and subsequent reintroduction of trastuzumab: activity and tolerability in patients with advanced human epidermal growth factor receptor 2-positive breast cancer.

artículo científico publicado en 2012

Pharmacokinetics of platinum after oral or intravenous cisplatin: a phase 1 study in 32 adult patients

artículo científico publicado en 2004

Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patients.

artículo científico publicado en 2003

Phase II study assessing lapatinib added to letrozole in patients with progressive disease under aromatase inhibitor in metastatic breast cancer-Study BES 06.

artículo científico publicado en 2013

Phase II trial of a paclitaxel-carboplatin combination in recurrent squamous cell carcinoma of the head and neck.

artículo científico publicado en 2001

Phase II trial of paclitaxel and uracil--tegafur in metastatic breast cancer. TEGATAX trial

scientific article published on 24 March 2011

Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3

scientific article published on 03 June 2018

Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive

artículo científico publicado en 2018

Pooled analyses of eribulin in metastatic breast cancer patients with at least one prior chemotherapy.

scientific article published on 13 May 2016

Predictors of re-excision for positive or close margins in breast-conservation therapy for pT1 tumors

scientific article published on 03 April 2008

Prevalence and management of pain in patients with metastatic cancer in Franche-Comté

artículo científico publicado en 2016

Primary lung sarcomas: long survivors obtained with iterative complete surgery

artículo científico publicado en 2001

Prognostic and predictive indicators in early-stage breast cancer and the role of genomic profiling: Focus on the Oncotype DX® Breast Recurrence Score Assay

artículo científico publicado en 2016

Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up

scientific article published on 01 July 2003

Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer

artículo científico publicado en 2005

Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study

artículo científico publicado en 2015

Prospective analysis of the impact of VEGF‐A gene polymorphisms on the pharmacodynamics of bevacizumab‐based therapy in metastatic breast cancer patients ⬇️

artículo científico publicado el 1 de junio de 2011

Prostate cancer screening: contrasting trends

artículo científico publicado en 2015

Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy

artículo científico publicado en 2011

Randomized phase II trial of first-line trastuzumab plus docetaxel and capecitabine compared with trastuzumab plus docetaxel in HER2-positive metastatic breast cancer.

artículo científico publicado en 2009

Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity.

artículo científico publicado en 2016

Renal safety of ibandronate 6 mg infused over 15 min versus 60 min in breast cancer patients with bone metastases: a randomized open-label equivalence trial

artículo científico publicado en 2011

Reply to the letter to the editor 'patients' preference and informed consent' by Pumo et al

artículo científico publicado en 2015

Report of a young man with three successive curable cancers

artículo científico publicado en 2007

Response rates: a valuable signal of promising activity?

artículo científico publicado en 2009

Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer.

artículo científico publicado en 2004

Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer

artículo científico publicado en 2003

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer.

artículo científico publicado en 2017

Safety and efficacy of cabazitaxel in the docetaxel-treated patients with hormone-refractory prostate cancer.

artículo científico

Safety profile of new anticancer drugs.

artículo científico publicado en 2010

Screening for prostate cancer: growth without control.

artículo científico publicado en 2011

Sequential taxane and anthracycline-containing neoadjuvant regimens: the sequential order impact

scientific article published on 07 August 2010

Social stratification, risk factor prevalence and cancer screening attendance.

artículo científico publicado en 2015

Specific anticancer treatments in the last 3 months of life: a French experience.

artículo científico publicado en 2012

Splenic lymphoma with villous lymphocytes: dissociated response with fludarabin

artículo científico publicado en 1999

Squamous cell carcinoma of the head and neck: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

artículo científico publicado en 2008

Squamous cell carcinoma of the head and neck: ESMO clinical recommendations for diagnosis, treatment and follow-up

artículo científico publicado en 2007

Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study.

artículo científico publicado en 2014

Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine

artículo científico publicado en 2018

Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II study

artículo científico publicado en 2014

Switching between intravenous and subcutaneous trastuzumab: Safety results from the PrefHer trial.

artículo científico publicado en 2017

The efficacy of chemotherapy with docetaxel and paclitaxel in anthracycline-resistant breast cancer (Review).

artículo científico publicado en 1999

The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab.

artículo científico publicado en 2008

The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy

artículo científico publicado en 2001

Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study.

artículo científico publicado en 2016

Trastuzumab duration effects within patient prognostic subgroups in the PHARE trial.

artículo científico publicado en 2014

Uptake of breast cancer screening in women aged over 75 years: a controversy to come?

artículo científico publicado en 2011

Why the results of adjuvant pertuzumab in HER2-positive early breast cancer has been received as a mitigate success?

scientific article published on 09 November 2017

[Appropriate cytotoxic drug usages in solid tumors: conformity to official labelling and level of scientific evidence]

scientific article published on 01 October 2006

[Bevacizumab and taxanes in the first-line treatment of metastatic breast cancer : overall survival and subgroup analyses of the ATHENA study in France].

artículo científico publicado en 2014

[Breast cancer in two male dizygotic twins]

scientific article published on 01 February 2000

[Cancer of the larynx and the hypopharynx: anatomy, anatomopathology, clinical signals, TNM, therapy]

artículo científico publicado en 2000

[Chemotherapy for patients with local-regional recurrent or metastatic carcinoma of the head and neck]

scientific article published on 01 January 2003

[Cost effectiveness of Ligasure Precise versus surgical clips during axillary nodal dissection for breast cancer]

scientific article published on 01 June 2006

[Duodenal Burkitt lymphoma in an HIV-negative patient: a medical emergency]

scientific article published on 01 April 2000

[Economic assessment of the routine use of Oncotype DX® assay for early breast cancer in Franche-Comte region].

artículo científico publicado en 2014

[Edifice program: analysis of screening exam practices for cancer in France]

artículo científico publicado en 2008

[Follow-up in patients with early breast cancer]

artículo científico publicado en 2011

[Immunotherapy: an emerging strategies against prostate castration resistant cancer]

scientific article published on 01 July 2012

[Induction chemotherapy in patients with head and neck cancer]

artículo científico publicado en 2006

[KIT and KIT: from biology to clinical use].

artículo científico publicado en 2012

[Pemetrexed development in oncology]

artículo científico publicado en 2007

[Primary adenocarcinoma of the lacrimal glands. A case]

artículo científico publicado en 1994

[Safety and efficacy of bevacizumab combined with taxanes in the first-line treatment of metastatic breast cancer: ATHENA study-France]

artículo científico publicado en 2012

[Severe hypocalcemia after treatment with diphosphonates and aminoglycosides]

scientific article published on 01 April 1994

[Value of neo-angiogenesis evaluation in cancer of the breast]

scientific article published on 01 December 1996

[Vertebral osteosarcoma. Review of the literature apropos of a case]

scientific article published on 01 July 1995

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda